These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21176767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of sulfasalazine in rheumatic diseases.
    Fuchs HA.
    Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Is the cure worse than the disease?
    Sacks R.
    Aust Fam Physician; 2001 Jul; 30(7):679-80. PubMed ID: 11558203
    [No Abstract] [Full Text] [Related]

  • 5. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH, Morris IM, Mattingly PC.
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract] [Full Text] [Related]

  • 6. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA.
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract] [Full Text] [Related]

  • 7. Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis.
    Soejima M, Kawaguchi Y, Hara M, Kamatani N.
    J Rheumatol; 2008 Apr; 35(4):724. PubMed ID: 18398952
    [No Abstract] [Full Text] [Related]

  • 8. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
    Taniguchi A, Urano W, Tanaka E, Furihata S, Kamitsuji S, Inoue E, Yamanaka M, Yamanaka H, Kamatani N.
    Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
    Nurmohamed MT, Soesan M, van Oers MH, Dijkmans BA, van Soesbergen RM.
    Rheumatology (Oxford); 2000 Dec; 39(12):1431-3. PubMed ID: 11136894
    [No Abstract] [Full Text] [Related]

  • 10. Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
    Ganu MA, Ganu AS.
    J Assoc Physicians India; 2011 Feb; 59():83-6. PubMed ID: 21751641
    [Abstract] [Full Text] [Related]

  • 11. Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
    Ghosh S, Jain VK, Chaudhuri S, Mathur SK.
    Indian J Dermatol Venereol Leprol; 2013 Feb; 79(4):541-4. PubMed ID: 23760333
    [No Abstract] [Full Text] [Related]

  • 12. Primary tuberculosis masquerading as gingival enlargement.
    Gill JS, Sandhu S, Gill S.
    Br Dent J; 2010 Apr 24; 208(8):343-5. PubMed ID: 20418829
    [Abstract] [Full Text] [Related]

  • 13. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL, van Gestel AM, van de Putte LB.
    Br J Rheumatol; 1995 Nov 24; 34 Suppl 2():40-2. PubMed ID: 8535648
    [Abstract] [Full Text] [Related]

  • 14. Two is better than one? Combination therapy in rheumatoid arthritis.
    Choy EH.
    Rheumatology (Oxford); 2004 Oct 24; 43(10):1205-7. PubMed ID: 15226519
    [No Abstract] [Full Text] [Related]

  • 15. Current concepts in the management of rheumatoid arthritis.
    Murphy NG.
    Del Med J; 1992 Apr 24; 64(4):257-64. PubMed ID: 1352263
    [No Abstract] [Full Text] [Related]

  • 16. Sulfasalazine for the management of juvenile rheumatoid arthritis.
    Brooks CD.
    J Rheumatol; 2001 Apr 24; 28(4):845-53. PubMed ID: 11327261
    [Abstract] [Full Text] [Related]

  • 17. Images in clinical medicine. Gingival hypertrophy and leukemia.
    Tjwa E, Mattijssen V.
    N Engl J Med; 2008 Oct 16; 359(16):e21. PubMed ID: 18923168
    [No Abstract] [Full Text] [Related]

  • 18. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.
    Semin Arthritis Rheum; 2007 Oct 16; 37(2):99-111. PubMed ID: 17391739
    [Abstract] [Full Text] [Related]

  • 19. [A chronic gingival hypertrophy].
    Aslangul E, Gadhoum H, Badoual C, Szwebel T, Perrot S, Le Jeunne C.
    Rev Med Interne; 2009 Mar 16; 30(3):260-1. PubMed ID: 18547685
    [No Abstract] [Full Text] [Related]

  • 20. [Gingival hypertrophy induced by cyclosporin A in heart transplant patients].
    Rodriguez y Baena R, Rizzo S, Piacentini C, Mirco M, Burrai L.
    Minerva Stomatol; 1990 May 16; 39(5):361-5. PubMed ID: 2381399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.